BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 08, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

XP21279: Completed Phase IIb enrollment

XenoPort disclosed in its 2Q11 earnings that it completed enrollment of about 48 PD patients with motor fluctuations in a double-blind, U.S. Phase IIb trial evaluating...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >